Age and Gender Heterogeneity in Adverse Drug Reactions Associated with Hemp Use: Evidence from the FDA Pharmacovigilance Data in the Last Two Decades | Synapse
February 13, 2026Open Access
Age and Gender Heterogeneity in Adverse Drug Reactions Associated with Hemp Use: Evidence from the FDA Pharmacovigilance Data in the Last Two Decades
Key Points
The aim is to explore how age and gender impact adverse drug reactions related to hemp-derived products.
Analyzed FDA pharmacovigilance data from the last two decades.
Examined adverse drug reactions associated with hemp use.
Compared incidence rates by age and gender.
Identified serious neurological and psychiatric events linked to hemp use.
Observed significant variation in adverse reactions based on age.
Noted gender differences in the severity and type of adverse drug reactions.
Abstract
Use of hemp-derived products are associated with adverse drug reactions, including serious neurological and psychiatric events, with marked heterogeneity by age and gender.